Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 20 Jan 2022 |
2 | REPLY TO FORMALITY CHECK(MIS-F) | 05 Mar 2022 |
3 | Reply to Exam Report (MIS-R) | 19 Jul 2022 |
4 | Journal Copy | 14 Dec 2022 |
5 | Journal Copy | 14 Dec 2022 |
6 | TM-O(NOTICE OF OPPOSITION) | 16 Feb 2023 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 05 Dec 2023 |
8 | Order | 24 Apr 2024 |
1 | Application(5293100) Keep Pending | 13118625 | 5524538 | 03 Mar 2022 |
2 | Opposition Notice | 15359007 | 5986902 | 05 Jun 2023 |
3 | Hearing Notice | 16467628 | 6327472 | 06 Nov 2023 |
Trademark was applied on 20 January 2022 with IP India.
Proprietor of Dapagza is EMCURE PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Dapagza is Abandoned.
Application number alloted to the trademark is 5293100.
Aditya & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE